Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Dobson

Showing results (511-520 of 516) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 516 results.
Molecular Cell|May 7, 2016
The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse ModelVaishali Kakkar, Cecilia Månsson, Eduardo P de Mattos, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicityMichele Perni, Céline Galvagnion, Alexander Maltsev, et al.
Nature Communications|January 16, 2019
Trodusquemine enhances Aβ<sub>42</sub> aggregation but suppresses its toxicity by displacing oligomers from cell membranesRyan Limbocker, Sean Chia, Francesco S Ruggeri, et al.
Plos One|February 20, 2014
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's diseaseGergely Tóth, Shyra J Gardai, Wagner Zago, et al.
Frontiers in Neuroscience|July 5, 2021
Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their OligomersRyan Limbocker, Roxine Staats, Sean Chia, et al.
Frontiers in Cell and Developmental Biology|April 8, 2021
Comparative Studies in the A30P and A53T α-Synuclein <i>C. elegans</i> Strains to Investigate the Molecular Origins of Parkinson's DiseaseMichele Perni, Annemieke van der Goot, Ryan Limbocker, et al.
Pageof 52

Showing results (511-520 of 516) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 516 results.
Molecular Cell|May 7, 2016
The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse ModelVaishali Kakkar, Cecilia Månsson, Eduardo P de Mattos, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicityMichele Perni, Céline Galvagnion, Alexander Maltsev, et al.
Nature Communications|January 16, 2019
Trodusquemine enhances Aβ<sub>42</sub> aggregation but suppresses its toxicity by displacing oligomers from cell membranesRyan Limbocker, Sean Chia, Francesco S Ruggeri, et al.
Plos One|February 20, 2014
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's diseaseGergely Tóth, Shyra J Gardai, Wagner Zago, et al.
Frontiers in Neuroscience|July 5, 2021
Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their OligomersRyan Limbocker, Roxine Staats, Sean Chia, et al.
Frontiers in Cell and Developmental Biology|April 8, 2021
Comparative Studies in the A30P and A53T α-Synuclein <i>C. elegans</i> Strains to Investigate the Molecular Origins of Parkinson's DiseaseMichele Perni, Annemieke van der Goot, Ryan Limbocker, et al.
Pageof 52